Medpace
MEDP----
Medpace (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Medpace Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$570.67-5.11%
Forecast & RatingHold
13analysts
- Strong buy7.69%
- Buy7.69%
- Hold76.92%
- Sell7.69%
- Strong sell0.00%
News
- Market Beat · 2 hours ago
Medpace (NASDAQ:MEDP) Price Target Raised to $609.00 at Truist Financial
- rttnews · 10 hours ago
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVB
- rttnews · 17 hours ago
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus
- Tip Ranks · 21 hours ago
Charles Rhyee Maintains Hold Rating, Raises Price Target to $492 Amid Near-Term Strength and 2027 Metabolic Concentration Risks
- PUBT · 1 day ago, 03:11 PM
Medpace FY26 Q2 net income rises to $121.36 million; revenue climbs 17.2% to $707.33 million
- US Stock Market Update · 1 day ago, 01:42 PM
Medpace soars 15% after Q2 beat, raised 2026 guidance
